Structures by: Abdelbaky M. S.
Total: 8
C16H10LiO9Y,2(H2O)
C16H10LiO9Y,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 15 5739-5746
a=11.6415(7)Å b=16.0920(4)Å c=13.2243(8)Å
α=90° β=132.228(11)° γ=90°
Poly[aqua(μ~5~-2,5-dicarboxybenzene-1,4-dicarboxylato)strontium]
C10H6O9Sr
Acta Crystallographica Section E (2020) 76, 3 354-359
a=25.8191(7)Å b=11.9726(3)Å c=7.1467(2)Å
α=90° β=90.662(2)° γ=90°
3-(Adamantan-1-yl)-4-(4-fluorophenyl)-1-[(4-phenylpiperazin-1-yl)methyl]-4,5-dihydro-1<i>H</i>-1,2,4-triazole-5-thione
C29H34FN5S
Acta Crystallographica Section E (2017) 73, 8 1135-1139
a=10.4173(5)Å b=10.9849(5)Å c=12.0002(6)Å
α=72.769(2)° β=84.623(2)° γ=89.244(2)°
3-(Adamantan-1-yl)-4-(4-fluorophenyl)-1-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-4,5-dihydro-1<i>H</i>-1,2,4-triazole-5-thione
C30H36FN5OS
Acta Crystallographica Section E (2017) 73, 8 1135-1139
a=11.3074(7)Å b=12.1576(8)Å c=20.4976(13)Å
α=90° β=101.328(2)° γ=90°
4-Phenylpiperazin-1-ium 6-chloro-5-isopropyl-2,4-dioxopyrimidin-1-ide
C10H15N2,C7H8ClN2O2
Acta Crystallographica Section E (2015) 71, 8 956-959
a=20.5012(3)Å b=7.45650(10)Å c=23.1414(3)Å
α=90° β=90.6390(10)° γ=90°
4-Phenylpiperazin-1-ium 6-chloro-5-ethyl-2,4-dioxopyrimidin-1-ide
C10H15N2,C6H6ClN2O2
Acta Crystallographica Section E (2015) 71, 8 956-959
a=21.6760(10)Å b=7.6446(5)Å c=20.5444(8)Å
α=90° β=95.065(5)° γ=90°
3-{[4-(2-Methoxyphenyl)piperazin-1-yl]methyl}-5-(thiophen-2-yl)-1,3,4-oxadiazole-2(3<i>H</i>)-thione
C18H20N4O2S2
Acta Crystallographica Section E (2016) 72, 2 269-272
a=15.2925(2)Å b=10.07450(10)Å c=11.97260(10)Å
α=90° β=93.4130(10)° γ=90°
(<i>E</i>)-1-{[(3,5-Dimethylphenyl)imino]methyl}naphthalen-2-ol
C19H17NO
Acta Crystallographica Section E (2015) 71, 7 o496-o497
a=6.2463(2)Å b=10.2438(3)Å c=23.0533(8)Å
α=90° β=90° γ=90°